Drug
Cromolyn clinical trials
Also written Sodium Cromoglycate, Gastrocrom and NasalCrom.
- studies test it
- 23
- open now
- 7
- in phase 3
- 5
- first study started
- 2008
Keep track of what changes. Save the cromolyn studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Combined with it in one product
Studies by the year they started
22 studies that test it; most in 2015 (3)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 6
- Phase 2
- 10
- Phase 3
- 5
- Phase 4
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 14
AZTherapies, Inc. (4) · LEO Pharma (2) · Universitaire Ziekenhuizen KU Leuven (2) · Northwestern University (1) · University of Tennessee (1) · University of California, San Diego (1) · Pulmotect, Inc. (1) · Shiraz University of Medical Sciences (1)
Often tested with
Tested in the same studies.
Cetirizine (1) · Ibuprofen (1) · Albuterol (1) · Guanfacine (1) · Ketotifen (1) · Choline (1) · Efavirenz (1) · Trastuzumab rezetecan (1)
Studies
Open first, then newest update. How each study uses cromolyn is read from its arms, and is right about nine times in ten.
Testing it · 23
- Reverse Triple Negative Immune Resistant Breast CancerRecruitingPhase 2Fudan UniversityNCT05076682Written as Sodium Cromoglicate
- Guanfacine and Cromolyn Sodium for POTS: The DBPOTS TrialNot yet recruitingEarly Phase 1Johns Hopkins UniversityNCT07757555Written as Cromolyn Sodium
- Novel Strategies for Reducing Burn Scar ItchRecruitingPhase 3The University of Texas Medical Branch, GalvestonNCT06801626Written as Famotidine and 4% topical cromolyn sodium
- PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALSRecruitingPhase 2PhenoNet, Inc.NCT07142291Written as Cromolyn Sodium (34.2 mg BID)
- Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung CancerNot yet recruitingPhase 1Carcinex IncNCT07675876Written as Cromolyn Sodium
- Mast Cell Treatment in Post-tick Bite Illness (PTBI)Not yet recruitingPhase 2University of North Carolina, Chapel HillNCT07526558Written as Cromolyn Sodium
- Cromoglicate Adjunctive Therapy for Outpatients With SchizophreniaRecruitingPhase 1/2Vishwajit Nimgaonkar, MD PhDNCT03794076Written as Cromoglycate
- Cromoglicate in PsoriasisCompletedPhase 2LEO PharmaNCT01722812Written as Cromoglicate
- Cromoglicate in MastocytosisTerminatedPhase 2LEO PharmaNCT01701843Written as Cromoglicate
- Mast Cells in Male Pelvic Pain and and Lower Urinary Tract DysfunctionCompletedEarly Phase 1Northwestern UniversityNCT03167216Written as Cromolyn Sodium
- Cromolyn Sodium for Treatment of COVID-19 PneumoniaTerminatedPhase 3Texas Tech University Health Sciences Center, El PasoNCT05077917Written as Cromolyn Sodium
- Mast Cells in Acid-induced Intestinal PermeabilityTerminatedPhase 4Universitaire Ziekenhuizen KU LeuvenNCT02664051Written as Nalcrom
- Oral Cromolyn Sodium for the Treatment of Eosinophilic EsophagitisCompletedPhase 4University of TennesseeNCT02371941Written as oral cromolyn sodium
- Influence of Cromones on Eucapnic Hyperventilation (EVH)-Test in Young (Elite) Athletes Who Tested Positive for EIB.TerminatedPhase 3Universitaire Ziekenhuizen KU LeuvenNCT04408664Written as Sodium Cromoglycate
- Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy VolunteersCompletedPhase 1AZTherapies, Inc.NCT04570644Written as ALZT-OP1 (cromolyn and ibuprofen) ALZT-OP1a (cromolyn) and ALZT-OP1b (ibuprofen)
- Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)WithdrawnPhase 2AZTherapies, Inc.NCT03202147Written as Cromolyn
- Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's DiseaseCompletedPhase 3AZTherapies, Inc.NCT02547818Written as ALZT-OP1a
- A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS DiseaseTerminatedPhase 2AZTherapies, Inc.NCT04428775Written as ALZT-OP1a (cromolyn)
- An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated ErythemaCompletedPhase 1/2University of California, San DiegoNCT01933464Written as Cromolyn Sodium
- Cromolyn Detection of Silent AspirationTerminatedPhase 1University of California, San FranciscoNCT01841307Written as Cromolyn Sodium
Codes
What other systems call cromolyn · ClinicalTrials.gg INT007384
- MeSH (NLM) D004205Cromolyn SodiumConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) Y0TK0FS77WCROMOLYNConfirmed FDA, NLM
- RxNorm 42612One source FDA
- NCI Thesaurus C61691CromolynOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D004205 | Cromolyn Sodium | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | Y0TK0FS77W | CROMOLYN | Confirmed FDA, NLM |
| RxNorm | 42612 | — | One source FDA |
| NCI Thesaurus | C61691 | Cromolyn | One source FDA |
Also registered as cromolyn sodium (UNII Q2WXR1I0PK · RxNorm 3538).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.